Deirdre M. B. Hickey

1.8k total citations
40 papers, 1.3k citations indexed

About

Deirdre M. B. Hickey is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Deirdre M. B. Hickey has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 16 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Deirdre M. B. Hickey's work include Synthesis and Catalytic Reactions (7 papers), Synthesis of β-Lactam Compounds (6 papers) and Synthesis and Biological Evaluation (5 papers). Deirdre M. B. Hickey is often cited by papers focused on Synthesis and Catalytic Reactions (7 papers), Synthesis of β-Lactam Compounds (6 papers) and Synthesis and Biological Evaluation (5 papers). Deirdre M. B. Hickey collaborates with scholars based in United Kingdom, United States and China. Deirdre M. B. Hickey's co-authors include Robert J. Ife, Colin H. Macphee, Colin A. Leach, Kitty Moores, Helen Boyd, Kevin J. Milliner, David G. Tew, Keith E. Suckling, Christopher J. Moody and Charles W. Rees and has published in prestigious journals such as Biochemistry, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Deirdre M. B. Hickey

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deirdre M. B. Hickey United Kingdom 20 516 387 382 230 168 40 1.3k
Colin A. Leach United Kingdom 18 414 0.8× 211 0.5× 417 1.1× 217 0.9× 141 0.8× 32 1.1k
Robert J. Ife United Kingdom 23 865 1.7× 417 1.1× 432 1.1× 242 1.1× 138 0.8× 52 1.7k
Hisashi Shinkai Japan 14 573 1.1× 291 0.8× 498 1.3× 158 0.7× 436 2.6× 27 1.6k
Marcos L. Sznaidman United States 9 1.1k 2.1× 181 0.5× 242 0.6× 161 0.7× 99 0.6× 25 1.3k
John K. Dickson United States 17 499 1.0× 351 0.9× 232 0.6× 95 0.4× 124 0.7× 34 1.1k
Bruce J. Auerbach United States 21 480 0.9× 142 0.4× 605 1.6× 186 0.8× 407 2.4× 40 1.4k
Richard Sulsky United States 12 640 1.2× 203 0.5× 129 0.3× 108 0.5× 94 0.6× 18 1.1k
Robert J. DeVita United States 26 770 1.5× 576 1.5× 257 0.7× 75 0.3× 280 1.7× 71 1.8k
Pascal Grondin France 14 1.4k 2.7× 236 0.6× 478 1.3× 140 0.6× 313 1.9× 16 2.1k
Kennan Marsh United States 10 848 1.6× 551 1.4× 366 1.0× 89 0.4× 183 1.1× 17 1.5k

Countries citing papers authored by Deirdre M. B. Hickey

Since Specialization
Citations

This map shows the geographic impact of Deirdre M. B. Hickey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deirdre M. B. Hickey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deirdre M. B. Hickey more than expected).

Fields of papers citing papers by Deirdre M. B. Hickey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deirdre M. B. Hickey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deirdre M. B. Hickey. The network helps show where Deirdre M. B. Hickey may publish in the future.

Co-authorship network of co-authors of Deirdre M. B. Hickey

This figure shows the co-authorship network connecting the top 25 collaborators of Deirdre M. B. Hickey. A scholar is included among the top collaborators of Deirdre M. B. Hickey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deirdre M. B. Hickey. Deirdre M. B. Hickey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borthwick, Alan D., John Liddle, Anne M. Exall, et al.. (2012). Pyridyl-2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists: Synthesis, Pharmacokinetics, and In Vivo Potency. Journal of Medicinal Chemistry. 55(2). 783–796. 54 indexed citations
2.
Kragol, Goran, Andrew K. Forrest, Hana Čipčić Paljetak, et al.. (2010). Synthesis and properties of macrolones characterized by two ether bonds in the linker. Bioorganic & Medicinal Chemistry. 18(17). 6578–6588. 22 indexed citations
3.
McCafferty, Gerald P., Mark Pullen, Charlene Wu, et al.. (2007). Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 293(1). R299–R305. 22 indexed citations
4.
McKeown, Stephen C., David F. Corbett, Aaron S. Goetz, et al.. (2007). Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor. Bioorganic & Medicinal Chemistry Letters. 17(6). 1584–1589. 56 indexed citations
5.
Bloomer, Jackie C., Murray J. B. Brown, Hung‐Yuan Cheng, et al.. (2003). The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 13(6). 1067–1070. 100 indexed citations
6.
Witherington, Jason, Vincent Bordas, Stephen L. Garland, et al.. (2003). 5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorganic & Medicinal Chemistry Letters. 13(9). 1577–1580. 95 indexed citations
7.
Boyd, Helen, Deirdre M. B. Hickey, Robert J. Ife, et al.. (2002). Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones. Bioorganic & Medicinal Chemistry Letters. 12(1). 51–55. 25 indexed citations
8.
Bloomer, Jackie C., Murray J. B. Brown, Hung‐Yuan Cheng, et al.. (2002). The discovery of SB-435495. Bioorganic & Medicinal Chemistry Letters. 12(18). 2603–2606. 34 indexed citations
9.
Dhanak, Dashyant, et al.. (2001). BASE INDUCED REACTION OF AN AZETIDIN-2-ONE: FORMATION OF A NOVEL [1,4]-DIAZEPINEDIONE. Synthetic Communications. 31(17). 2713–2718.
10.
Leach, Colin A., Deirdre M. B. Hickey, Robert J. Ife, et al.. (2001). Lipoprotein-associated PLA2 inhibition — a novel, non-lipid lowering strategy for atherosclerosis therapy. Il Farmaco. 56(1-2). 45–50. 40 indexed citations
11.
Forbes, Ian T., David G. Cooper, Deirdre M. B. Hickey, et al.. (2000). CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound. Bioorganic & Medicinal Chemistry Letters. 10(16). 1803–1806. 41 indexed citations
12.
Boyd, Helen, Deirdre M. B. Hickey, Robert J. Ife, et al.. (2000). N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 10(22). 2557–2561. 24 indexed citations
13.
Pinto, Ivan L., Helen Boyd, & Deirdre M. B. Hickey. (2000). natural product derived inhibitors of lipoprotein associated phospholipase a2, synthesis and activity of analogues of sb-253514. Bioorganic & Medicinal Chemistry Letters. 10(17). 2015–2017. 25 indexed citations
14.
Benson, G. Martin, David C. Grimsditch, Kitty Moores, et al.. (2000). Anti-atherosclerotic effect of SB-244323, a lipoprotein associated phospholipase A2 inhibitor, in WHHL rabbits. Atherosclerosis. 151(1). 166–166. 12 indexed citations
15.
Benson, G. Martin, David R. Alston, Deirdre M. B. Hickey, et al.. (1997). SK&F 97426-A: A Novel Bile Acid Sequestrant with Higher Affinities and Slower Dissociation Rates for Bile Acids in vitro Than Cholestyramine. Journal of Pharmaceutical Sciences. 86(1). 76–81. 16 indexed citations
16.
Suckling, Keith E., William Kerns, Andrew Gee, et al.. (1994). SK&F 99085/SR-9223i, a novel hypocholesterolemic agent with multiple anti-atherosclerotic properties, lowers plasma cholesterol in normocholesterolemic animals. Atherosclerosis. 109(1-2). 166–167. 2 indexed citations
17.
Benson, G. Martin, David R. Alston, Brian Bond, et al.. (1993). SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster. Atherosclerosis. 101(1). 51–60. 17 indexed citations
18.
19.
Merritt, Janet E., Trevor J. Hallam, Anthony Brown, et al.. (1991). Octimibate, a potent non‐prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. British Journal of Pharmacology. 102(1). 251–259. 30 indexed citations
20.
Merritt, Janet E., Anthony Brown, David G. Cooper, et al.. (1991). Primate vascular responses to octimibate, a non‐prostanoid agonist at the prostacyclin receptor. British Journal of Pharmacology. 102(1). 260–266. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colin A. Leach Breakdown of academic impact, for papers by Robert J. Ife Breakdown of academic impact, for papers by Hisashi Shinkai Breakdown of academic impact, for papers by Marcos L. Sznaidman Breakdown of academic impact, for papers by John K. Dickson Breakdown of academic impact, for papers by Bruce J. Auerbach Breakdown of academic impact, for papers by Richard Sulsky Breakdown of academic impact, for papers by Robert J. DeVita Breakdown of academic impact, for papers by Pascal Grondin Breakdown of academic impact, for papers by Kennan Marsh
Rankless by CCL
2026